UCB Ventures

UCB Ventures

UCB Ventures is a €150 million strategic corporate venture fund

UCB Ventures is a €150 million strategic corporate venture fund. The firm is interested in early-stage ventures, and has been in operations since 2017.

The firm looks to create value by providing novel insights and technologies that can transform the lives of patients that suffer from severe diseases. The diseases the fund aims to defeat include neurological diseases and muscular skeletal/bone. UCB Ventures looks to invest in companies such as MyHealthTeams, Locana, Rinri Therapeutics, and invests during seed and early Series rounds.

Timeline

Funded Companies

Company
Description
Website
Industry
Location

StrideBio, Inc. is a gene therapy company focused on creating and developing novel adeno-associated viral (AAV) vector technologies.

1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.